Prisca Boisguerin
Boisguerin, Prisca
VIAF ID: 30150565740906252656 (Personal)
Permalink: http://viaf.org/viaf/30150565740906252656
Preferred Forms
- 100 1 _ ‡a Boisguerin, Prisca
- 100 0 _ ‡a Prisca Boisguerin
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Cardiac mGluR1 metabotropic receptors in cardioprotection. | |
Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells. | |
Characterization and optimization of CADY/siRNA nanoparticles for an in vivo application. | |
Characterization of a putative phosphorylation switch: adaptation of SPOT synthesis to analyze PDZ domain regulation mechanisms | |
Chemical biology approaches reveal conserved features of a C-terminal processing PDZ protease | |
Comparison of cellular uptake using 22 CPPs in 4 different cell lines. | |
Computational design of a PDZ domain peptide inhibitor that rescues CFTR activity | |
Conception et étude de nouveaux peptides vecteurs cycliques | |
Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency | |
CtpB Assembles a Gated Protease Tunnel Regulating Cell-Cell Signaling during Spore Formation in Bacillus subtilis | |
Design and study of new cyclic cell-penetrating peptides. | |
Development and vectorization of CAL PDZ inhibiting peptides for the treatment of cystic fibrosis. | |
Développement d'une version synthétique de la sous-unité B de la toxine de Shiga avec une translocation vers le cytosol augmentée pour le développement de thérapies anticancéreuses innovantes. | |
Développement et vectorisation de peptides inhibiteurs du domaine PDZ de CAL pour le traitement de la mucoviscidose | |
Discovery of low-molecular-weight ligands for the AF6 PDZ domain | |
Domain Interaction Footprint: a multi-classification approach to predict domain-peptide interactions. | |
Generation and characterization of a rat monoclonal antibody specific for PCNA. | |
How to evaluate the cellular uptake of CPPs with fluorescence techniques: Dissecting methodological pitfalls associated to tryptophan-rich peptides | |
Identification of a linear epitope in sortilin that partakes in pro-neurotrophin binding. | |
Identification of Xin-repeat proteins as novel ligands of the SH3 domains of nebulin and nebulette and analysis of their interaction during myofibril formation and remodeling | |
In Vitro Assays to Assess Exon Skipping in Duchenne Muscular Dystrophy | |
Involvement of 14-3-3 protein post-translational modifications in Giardia duodenalis encystation. | |
Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide. | |
Optimization of peptide-plasmid DNA vectors formulation for gene delivery in cancer therapy exploring design of experiments | |
Optimization of the process of inverted peptides (PIPEPLUS) to screen PDZ domain ligands. | |
PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo. | |
Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides | |
Regulation of c-Src by binding to the PDZ domain of AF-6 | |
A retro-inverso cell-penetrating peptide for siRNA delivery. | |
RNase H-Assisted Imaging of Peroxynitrite in Living Cells with 5′-Boronic Acid Modified DNA | |
Sorting and pooling strategy: a novel tool to map a virus proteome for CD8 T-cell epitopes | |
A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR. | |
Stereochemical Preferences Modulate Affinity and Selectivity among Five PDZ Domains that Bind CFTR: Comparative Structural and Sequence Analyses | |
Synergie des interactions entre GAG et bicouche lipidique dans les mécanismes d'internalisation de peptides ciblant les GAG : développement d'un système de transport basé sur les CPP | |
Synergy of the interactions between GAGs and lipid bilayers in the internalization mechanisms of peptides targeting GAGs : development of a delivery system based on CPPs. | |
A synthetic B-subunit of Shiga toxin with enhanced cytosolic delivery efficiency for innovative anticancer immunotherapies | |
Systemic delivery of BH4 anti-apoptotic peptide using CPPs prevents cardiac ischemia-reperfusion injuries in vivo. | |
Using hydroxymethylphenoxy derivates with the SPOT technology to generate peptides with authentic C-termini |